During the current outbreak of novel coronavirus disease 2019 (COVID-19), frontline health-care workers are at high risk of contamination and spreading the infection. Hospital-related infections have been widely reported, with [health-care professionals](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30066-7/fulltext){#interrefs10} being disproportionately affected. Health-care workers who are involved in [airway management](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30084-9/fulltext){#interrefs20} of severely ill patients with COVID-19 are particularly at risk due to the use of intubators; for example, a proportion of anaesthesiologists working in Wuhan, China, [became infected](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30084-9/fulltext){#interrefs30} after performing endotracheal intubation on patients with confirmed COVID-19. Intubation can trigger aerosolisation of small particles containing the virus, and these particles can travel further distances when suspended in the air than when not aerosolised and be inhaled, increasing the risk of transmission. Therefore, anaesthesiologists, intensivists, and others members of the airway management team, [should be careful](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30418-9/fulltext){#interrefs40} when performing tracheal intubation for patients with COVID-19.

Considering that any patient who is admitted to the intensive care unit (ICU) might be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we present a [video](#sec1){ref-type="sec"} of tracheal intubation performed in an operating room, using two different devices for laryngoscopy ([video](#sec1){ref-type="sec"}). As recommended by airway management societies worldwide, we used a rapid sequence induction, and face mask ventilation was avoided. In part 1 of the [video](#sec1){ref-type="sec"}, the use of standard Macintosh laryngoscope for tracheal intubation places the face of the intubator very close to the patient, which puts the intubator at high risk of contamination from airway secretions. In part 2 of the [video](#sec1){ref-type="sec"}, the use of a videolaryngoscope allows the intubator to be further away from the patient and is therefore at reduced risk of exposure to airway secretions and contamination. The use of a single-use blade might also reduce the risk of patient-to-provider transmission compared with use of a reusable blade.

[Videolaryngoscopy](https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2487-5){#interrefs50} is an important tool in anticipated and unanticipated difficult intubation. Videolaryngoscopes are designed to improve visualisation of the glottis, aiming to decrease the time to successful intubation, increase first attempt intubation success rate, increase overall intubation success rate, reduce applied force, and reduce intubation-related complications.

After wide implementation of videolaryngoscopy in operating rooms, the rate of [difficult and failed intubations](https://bjanaesthesia.org/article/S0007-0912(18)30766-9/fulltext){#interrefs60} by skilled providers have declined significantly. For critically ill patients, the use of videolaryngoscopes is more recent than in operating rooms; however, their effectiveness in increasing first attempt success and reducing difficult intubation or complications related to intubation remains [controversial](https://bjanaesthesia.org/article/S0007-0912(17)31426-5/fulltext){#interrefs70}. However, after appropriate training and education, videolaryngoscopes can also be of great help for an experienced operator in both non-difficult and difficult intubation procedures in the ICU setting. This [reduction of difficult intubation](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30084-9/fulltext){#interrefs80} could thereby reduce patient-to-provider transmission of infectious disease and SARS-CoV-2 infection.

New respiratory viruses are emerging each year; to minimise the spread of disease, preventive measures should be taken for each tracheal intubation performed, such as the use of videolaryngoscopes, which allow indirect visualisation of the glottis. In the UK, guidance from the Royal College of Anaesthetists and the Intensive Care Society advises the use of videolaryngoscopes for intubation of patients with COVID-19. Worldwide, data suggest that 80% of intubations of these patients have been performed with videolaryngoscopes. It is worth noting that proficiency with videolaryngoscope is unlikely to be achieved if their use remains limited to predicted or unpredicted difficult intubation. Developing expertise in videolaryngoscopy will require frequent rather than occasional use, both in operating rooms and in ICUs.

Videolaryngoscopes do come in several varieties, and anaesthetists have to be familiar with the particular videolaryngoscope they are using. The UK national guidelines do also advocate that the most senior anaesthetist intubates patients, rather than junior anaesthetists or for those not familiar with the videolaryngoscope available, to avoid prolonging of the intubation attempt. The transition to videolaryngoscopy as a routine firstline option throughout anaesthetic and ICU practice has been [reported](https://bjanaesthesia.org/article/S0007-0912(17)54003-9/fulltext){#interrefs90} and is currently performed in the Montpellier University hospital and other hospitals across France. We believe that all patients with COVID-19, and ideally every patient during the pandemic, should be intubated using videolaryngoscopy.
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